337 related articles for article (PubMed ID: 26573545)
1. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.
Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP
Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
3. The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?
Goilav B; Putterman C
Semin Nephrol; 2015 Sep; 35(5):439-43. PubMed ID: 26573546
[TBL] [Abstract][Full Text] [Related]
4. Future Perspectives on Pathogenesis of Lupus Nephritis: Facts, Problems, and Potential Causal Therapy Modalities.
Rekvig OP; Thiyagarajan D; Pedersen HL; Horvei KD; Seredkina N
Am J Pathol; 2016 Nov; 186(11):2772-2782. PubMed ID: 27664472
[TBL] [Abstract][Full Text] [Related]
5. Lupus, DNase and defective disposal of cellular debris.
Walport MJ
Nat Genet; 2000 Jun; 25(2):135-6. PubMed ID: 10835621
[No Abstract] [Full Text] [Related]
6. Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis.
Fismen S; Hedberg A; Fenton KA; Jacobsen S; Krarup E; Kamper AL; Rekvig OP; Mortensen ES
Lupus; 2009 Jun; 18(7):597-607. PubMed ID: 19433459
[TBL] [Abstract][Full Text] [Related]
7. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
Mortensen ES; Rekvig OP
J Am Soc Nephrol; 2009 Apr; 20(4):696-704. PubMed ID: 19329762
[TBL] [Abstract][Full Text] [Related]
8. Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens.
Mjelle JE; Rekvig OP; Van Der Vlag J; Fenton KA
Autoimmunity; 2011 Aug; 44(5):373-83. PubMed ID: 21244336
[TBL] [Abstract][Full Text] [Related]
9. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
10. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.
Fismen S; Mortensen ES; Rekvig OP
Immunol Cell Biol; 2011 Jan; 89(1):90-9. PubMed ID: 20548325
[TBL] [Abstract][Full Text] [Related]
11. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
Suzuki N; Harada T; Mizushima Y; Sakane T
J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
[TBL] [Abstract][Full Text] [Related]
12. Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes.
Hedberg A; Fismen S; Fenton KA; Fenton C; Osterud B; Mortensen ES; Rekvig OP
Arthritis Rheum; 2011 Apr; 63(4):1065-75. PubMed ID: 21190297
[TBL] [Abstract][Full Text] [Related]
13. Glomerular targets for autoantibodies in lupus nephritis--an apoptotic origin.
Zykova SN; Seredkina NE; Rekvig OP
Ann N Y Acad Sci; 2007 Jun; 1108():1-10. PubMed ID: 17893965
[TBL] [Abstract][Full Text] [Related]
14. New immunosuppresor strategies in the treatment of murine lupus nephritis.
Alperovich G; Rama I; Lloberas N; Franquesa M; Poveda R; Gomà M; Herrero-Fresneda I; Cruzado JM; Bolaños N; Carrera M; Grinyó JM; Torras J
Lupus; 2007; 16(1):18-24. PubMed ID: 17283580
[TBL] [Abstract][Full Text] [Related]
15. Chromatin as a target antigen in human and murine lupus nephritis.
Hedberg A; Mortensen ES; Rekvig OP
Arthritis Res Ther; 2011 Apr; 13(2):214. PubMed ID: 21542875
[TBL] [Abstract][Full Text] [Related]
16. Lupus nephritis: enigmas, conflicting models and an emerging concept.
Seredkina N; Van Der Vlag J; Berden J; Mortensen E; Rekvig OP
Mol Med; 2013 Jul; 19(1):161-9. PubMed ID: 23752208
[TBL] [Abstract][Full Text] [Related]
17. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice.
Mjelle JE; Kalaaji M; Rekvig OP
Autoimmunity; 2009 Feb; 42(2):104-11. PubMed ID: 19005880
[TBL] [Abstract][Full Text] [Related]
18. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be.
Rekvig OP
Front Immunol; 2019; 10():1104. PubMed ID: 31156647
[TBL] [Abstract][Full Text] [Related]
19. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities.
Hedberg A; Fismen S; Fenton KA; Mortensen ES; Rekvig OP
Exp Dermatol; 2010 Aug; 19(8):e265-74. PubMed ID: 20500770
[TBL] [Abstract][Full Text] [Related]
20. Anti-DNA antibody subpopulations and lupus nephritis.
Rekvig OP; Kalaaji M; Nossent H
Autoimmun Rev; 2004 Feb; 3(2):1-6. PubMed ID: 15003181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
